Latest News

CMITT, a National Center for Biomedical Imaging and Bioengineering, has relocated from Massachusetts General Hospital to Yale University while maintaining its leadership team. With a focus on PET/MR imaging, CMITT remains dedicated to groundbreaking research, now poised to thrive within Yale's collaborative academic environment.

To learn more about dense breast tissue, we spoke to Kiran Sheikh, MD, a breast imaging specialist and radiologist at Yale Cancer Center. She explains the new FDA ruling, why it matters and how you can stay proactive about your breast health.

The study builds on a growing body of research suggesting 3D mammography could offer benefits over 2D imaging.

Researchers say fewer false positives and the overall higher cancer detection rate is a win-win and shows DBT is not over-diagnosing cancers.

Dr. Paris Lotfi talks with NBC Connecticut about the new FDA guidelines on informing women about dense breasts and shares guidance on supplemental breast screenings.

Yale researchers find people with stronger cravings for food or substances get “stuck” in a particular pattern of brain activity.

“We know it will find other cancers, but we haven’t proven that it actually saves lives,” said Dr. John Lewin, chief of breast imaging at Yale Cancer Center.

A new study, led by researchers at Yale School of Medicine and the Veterans Affairs National Center for PTSD, utilized positron emission tomography imaging with [11C]PBR28, a radiotracer to measure 18-kDa translocator protein to better understand microglia, the resident immune cells in the brain of individuals with PTSD.

Datasets that are too small may lead researchers to overlook relationships between the brain and behavior, a new study finds.